The Mitigating Role of Prescription Drug Monitoring Programs in the Abuse of Prescription Drugs

Birk, Erica; Waddell, Glen R.

doi:10.2139/ssrn.3037875

Cited by 7 publications

(11 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The studies reviewed here exploit variation in the timing of implementation of PDMPs and heterogeneity in PDMP attributes, including "must access" provisions, in difference-in-differences frameworks to identify the effect of PDMPs on various outcomes. Ayres and Jalal (2018), Buchmueller and Carey (2018), Meinhofer (2018), Sacks et al (2021), andBao et al (2018) analyze the impact of PDMPs on prescription drug utilization; Birk and Waddell (2017), Buchmueller and Carey (2018), Meinhofer (2018), andGrecu et al (2019) explore the effectiveness of PDMPs in reducing opioid poisoning or opioid-related drug overdose deaths; and Birk and Waddell (2017) and Grecu et al (2019) evaluate the impact of PDMP attributes on admissions to substance abuse treatment facilities. Ayres and Jalal (2018) and Meinhofer (2018) analyze the impact of PDMPs on retail opioid prescribing rates for the general population at the county and state levels, respectively.…”

Section: Contextmentioning

confidence: 99%

“…Buchmueller and Carey find a negative but insignificant effect of MA-PDMPs on opioid poisoning incidents in the Medicare population. Birk and Waddell (2017) and Grecu et al (2019) exploit variation in the timing of implementation of PDMPs and heterogeneity in PDMP attributes to identify the effect of PDMPs on substance abuse treatment admissions. 7 The main difference in the studies is the time period-Birk and Waddell use data from 1998 to 2017 while Grecu et al have data from 2003Grecu et al have data from to 2014 Both studies find that PDMPs with "must access" attributes result in larger reductions in opioidrelated drug treatment admissions than "voluntary access" PDMPs.…”

Section: Contextmentioning

confidence: 99%

“…(2018) analyze the impact of PDMPs on prescription drug utilization; Birk and Waddell (2017), Buchmueller and Carey (2018), Meinhofer (2018), and Grecu et al. (2019) explore the effectiveness of PDMPs in reducing opioid poisoning or opioid‐related drug overdose deaths; and Birk and Waddell (2017) and Grecu et al. (2019) evaluate the impact of PDMP attributes on admissions to substance abuse treatment facilities.…”

Section: Contextmentioning

confidence: 99%

“…Several economic studies evaluate the effect of PDMPs on opioid misuse and prescribing behavior 5 . Most of these studies rely on state level data in their analyses (e.g., Birk & Waddell, 2017; Buchmueller & Carey, 2018; Grecu et al., 2019; Meinhofer, 2018; Rutkow et al., 2015; Strickler et al., 2019). We add to this literature by analyzing the impact of “must access” PDMPs (MA‐PDMPs) on opioid prescribing behavior using more granular county‐level data.…”

Section: Introductionmentioning

confidence: 99%

“…St. Louis County, which accounts for more than half of Missouri's population, has implemented a PDMP and appeals to other counties and cities in Missouri to conjoin (PDMPTTAC, 2019).7 Note thatGrecu et al (2019) focus on the "must access" mandate whileBirk and Waddell (2017) analyze the effectiveness of multiple attributes of PDMPs.8 A recent working paper,Guth and Zhang (2022), also explores geographic spillovers associated with PDMPs. Our study differs from this…”

mentioning

confidence: 99%

See 4 more Smart Citations

The effect of Prescription Drug Monitoring Programs on county‐level opioid prescribing practices and spillovers

Shakya

Ruseski

2023

Contemporary Economic Policy

View full text Add to dashboard Cite

Most states now legally mandate providers to access the Prescription Drug Monitoring Program (PDMP) database before prescribing controlled substances like opioids. We exploit variation in the adoption of these "must access" mandates between 2010 and 2017 to evaluate their impact on prescribing behavior. We find that counties in "must access" PDMP states have 5.5 fewer retail opioid prescriptions per 100 persons compared to counties in "voluntary access" PDMP states. We find evidence of geographic spillovers in opioid prescribing behavior. Our results underscore the importance recognizing the potential for cross-border shopping when designing interventions to combat opioid misuse.

show abstract

Section: Contextmentioning

confidence: 99%

Section: Contextmentioning

confidence: 99%

Section: Contextmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

The effect of Prescription Drug Monitoring Programs on county‐level opioid prescribing practices and spillovers

Shakya

Ruseski

2023

Contemporary Economic Policy

View full text Add to dashboard Cite

show abstract

The effect of combat deployments on veteran opioid abuse

Cesur,

Sabia,

Bradford

2024

Health Economics

View full text Add to dashboard Cite

Grim national statistics about the U.S. opioid crisis are increasingly well known to the American public. Far less well known is that U.S. servicemembers are at ground zero of the epidemic, with veterans facing an overdose death rate of up to twice that of civilians. Exploiting a quasi‐experiment in overseas deployment assignment, this study estimates the causal impact of combat exposure among the deployed in the Global War on Terrorism on opioid abuse. We find that exposure to war theater substantially increased the risk of prescription painkiller abuse and illicit heroin use among active duty servicemen. The magnitudes of our estimates imply lower‐bound combat exposure‐induced healthcare costs of $1.04 billion per year for prescription painkiller abuse and $470 million per year for heroin use.

show abstract

Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse

Grecu¹,

Dave²,

Saffer³

2018

J Policy Anal Manage

114

138

View full text Add to dashboard Cite

Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute a key policy targeting access to non‐medical use of Rx drugs. Based on objective indicators of abuse as measured by substance abuse treatment admissions and mortality related to Rx drugs, estimates do not suggest any substantial effects of instituting an operational PDMP. We find, however, that mandatory‐access provisions, which raised PDMP utilization rates by actually requiring providers to query the PDMP prior to prescribing a controlled drug, are significantly associated with a reduction in Rx drug abuse. The effects are driven primarily by a reduction in opioid abuse, generally strongest among young adults (ages 18 to 24), and underscore important dynamics in the policy response. Robustness checks are consistent with a causal interpretation of these effects. We also assess potential spillovers of mandatory PDMPs on the use of other illicit drugs and find a complementary reduction in admissions related to cocaine and marijuana abuse.

show abstract

The Mitigating Role of Prescription Drug Monitoring Programs in the Abuse of Prescription Drugs

Cited by 7 publications

References 16 publications

The effect of Prescription Drug Monitoring Programs on county‐level opioid prescribing practices and spillovers

The effect of Prescription Drug Monitoring Programs on county‐level opioid prescribing practices and spillovers

The effect of combat deployments on veteran opioid abuse

Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse

Contact Info

Product

Resources

About